Matches in SemOpenAlex for { <https://semopenalex.org/work/W1910102915> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W1910102915 endingPage "5" @default.
- W1910102915 startingPage "5" @default.
- W1910102915 abstract "In recent years the course processes of chronic glomerulonephritis viewed from a position of influence nonimmune factors. In the present research, in contrast to the existing, it is researched an intensity of acute phase response depending on the stage of chronic kidney disease and studied the dynamics of changes of inflammatory response against the background of different pharmacological regimens.Methods. Using standard biochemical tests to study the intensity of inflammatory response in chronic kidney disease of serum are studied protein content of acute phase: ceruloplasmin, haptoglobin, α-2-macroglobulin. The study involved 100 people. 80 of these people have chronic kidney disease. At hypertension was prescribed medicine of inhibitor of angiotensin-converting enzyme in combination with calcium channel blockers on a background of basic therapy.Results. In all groups of patients before treatment it is recorded a high activity of serum of investigated proteins of acute phase, reflecting the presence of active inflammation. In the context of the treatment an inflammation activity is decreased, causing regression of the inflammatory response indicators. With the growth of the studied parameters in the 2 - 2, 5 times it is diagnosed a high degree of inflammatory response. This degree was determined in patients with chronic kidney disease of third stage. The lowest degree of inflammatory response was typical for patients with first stage of the disease, improving all parameters were within 1.3 times relative to control values.Conclusions. The inflammation intensity in chronic kidney disease depends on the progression of renal dysfunction. To correct the intensity of inflammatory response is recommended to use the fixed combination of inhibitor of angiotensin-converting enzyme (fozinopril) and calcium channel blockers (diltiazem)." @default.
- W1910102915 created "2016-06-24" @default.
- W1910102915 creator A5034525933 @default.
- W1910102915 date "2015-03-19" @default.
- W1910102915 modified "2023-09-25" @default.
- W1910102915 title "Indicators of inflammatory response in chronic kidney disease and their dynamics on the background of pharmacological correction" @default.
- W1910102915 cites W1968587005 @default.
- W1910102915 cites W2016859397 @default.
- W1910102915 cites W2017015351 @default.
- W1910102915 cites W2084445790 @default.
- W1910102915 cites W2154830635 @default.
- W1910102915 cites W34777226 @default.
- W1910102915 cites W2394784667 @default.
- W1910102915 doi "https://doi.org/10.15587/2313-8416.2015.38676" @default.
- W1910102915 hasPublicationYear "2015" @default.
- W1910102915 type Work @default.
- W1910102915 sameAs 1910102915 @default.
- W1910102915 citedByCount "0" @default.
- W1910102915 crossrefType "journal-article" @default.
- W1910102915 hasAuthorship W1910102915A5034525933 @default.
- W1910102915 hasBestOaLocation W19101029151 @default.
- W1910102915 hasConcept C126322002 @default.
- W1910102915 hasConcept C151730666 @default.
- W1910102915 hasConcept C203014093 @default.
- W1910102915 hasConcept C206396517 @default.
- W1910102915 hasConcept C2776914184 @default.
- W1910102915 hasConcept C2778653478 @default.
- W1910102915 hasConcept C2779134260 @default.
- W1910102915 hasConcept C2779343474 @default.
- W1910102915 hasConcept C2780091579 @default.
- W1910102915 hasConcept C28452662 @default.
- W1910102915 hasConcept C57194454 @default.
- W1910102915 hasConcept C71924100 @default.
- W1910102915 hasConcept C86803240 @default.
- W1910102915 hasConceptScore W1910102915C126322002 @default.
- W1910102915 hasConceptScore W1910102915C151730666 @default.
- W1910102915 hasConceptScore W1910102915C203014093 @default.
- W1910102915 hasConceptScore W1910102915C206396517 @default.
- W1910102915 hasConceptScore W1910102915C2776914184 @default.
- W1910102915 hasConceptScore W1910102915C2778653478 @default.
- W1910102915 hasConceptScore W1910102915C2779134260 @default.
- W1910102915 hasConceptScore W1910102915C2779343474 @default.
- W1910102915 hasConceptScore W1910102915C2780091579 @default.
- W1910102915 hasConceptScore W1910102915C28452662 @default.
- W1910102915 hasConceptScore W1910102915C57194454 @default.
- W1910102915 hasConceptScore W1910102915C71924100 @default.
- W1910102915 hasConceptScore W1910102915C86803240 @default.
- W1910102915 hasIssue "4(8)" @default.
- W1910102915 hasLocation W19101029151 @default.
- W1910102915 hasLocation W19101029152 @default.
- W1910102915 hasOpenAccess W1910102915 @default.
- W1910102915 hasPrimaryLocation W19101029151 @default.
- W1910102915 hasRelatedWork W108799148 @default.
- W1910102915 hasRelatedWork W1910102915 @default.
- W1910102915 hasRelatedWork W2023114844 @default.
- W1910102915 hasRelatedWork W2084998323 @default.
- W1910102915 hasRelatedWork W2085524414 @default.
- W1910102915 hasRelatedWork W2169236836 @default.
- W1910102915 hasRelatedWork W2406851659 @default.
- W1910102915 hasRelatedWork W2411661067 @default.
- W1910102915 hasRelatedWork W2923133136 @default.
- W1910102915 hasRelatedWork W3194806272 @default.
- W1910102915 hasVolume "3" @default.
- W1910102915 isParatext "false" @default.
- W1910102915 isRetracted "false" @default.
- W1910102915 magId "1910102915" @default.
- W1910102915 workType "article" @default.